These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse. Savolainen MH; Albert K; Airavaara M; Myöhänen TT Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627 [TBL] [Abstract][Full Text] [Related]
108. The Contribution of Longhena F; Faustini G; Missale C; Pizzi M; Spano P; Bellucci A Neural Plast; 2017; 2017():5012129. PubMed ID: 28133550 [TBL] [Abstract][Full Text] [Related]
109. Evaluation of Models of Parkinson's Disease. Jagmag SA; Tripathi N; Shukla SD; Maiti S; Khurana S Front Neurosci; 2015; 9():503. PubMed ID: 26834536 [TBL] [Abstract][Full Text] [Related]
110. G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice. Guo Y; Liu S; Zhang X; Wang L; Gao J; Han A; Hao A Lab Invest; 2015 Dec; 95(12):1439-49. PubMed ID: 26524416 [TBL] [Abstract][Full Text] [Related]
111. Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice. Willard AM; Bouchard RS; Gittis AH Neuroscience; 2015 Aug; 301():254-67. PubMed ID: 26067595 [TBL] [Abstract][Full Text] [Related]
112. Molecular details of α-synuclein membrane association revealed by neutrons and photons. Jiang Z; Hess SK; Heinrich F; Lee JC J Phys Chem B; 2015 Apr; 119(14):4812-23. PubMed ID: 25790164 [TBL] [Abstract][Full Text] [Related]
113. Models of α-synuclein aggregation in Parkinson's disease. Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491 [TBL] [Abstract][Full Text] [Related]
114. A nucleoprotein-enriched diet suppresses dopaminergic neuronal cell loss and motor deficit in mice with MPTP-induced Parkinson's disease. Kiriyama K; Ohtaki H; Kobayashi N; Murai N; Matsumoto M; Sasaki S; Sawa C; Satoh K; Matsunaga M; Shioda S J Mol Neurosci; 2015 Mar; 55(3):803-11. PubMed ID: 25303858 [TBL] [Abstract][Full Text] [Related]
115. Normal black kidney. Yarmohamadi A; Rezayat AR; Memar B; Rahimi HR; Cand P Can Urol Assoc J; 2014 Mar; 8(3-4):E282-6. PubMed ID: 24839502 [TBL] [Abstract][Full Text] [Related]
116. Biomedical and clinical promises of human pluripotent stem cells for neurological disorders. Jongkamonwiwat N; Noisa P Biomed Res Int; 2013; 2013():656531. PubMed ID: 24171168 [TBL] [Abstract][Full Text] [Related]
117. Membrane remodeling by α-synuclein and effects on amyloid formation. Jiang Z; de Messieres M; Lee JC J Am Chem Soc; 2013 Oct; 135(43):15970-3. PubMed ID: 24099487 [TBL] [Abstract][Full Text] [Related]
118. α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles. Varkey J; Mizuno N; Hegde BG; Cheng N; Steven AC; Langen R J Biol Chem; 2013 Jun; 288(24):17620-30. PubMed ID: 23609437 [TBL] [Abstract][Full Text] [Related]
119. MPTP mouse models of Parkinson's disease: an update. Meredith GE; Rademacher DJ J Parkinsons Dis; 2011; 1(1):19-33. PubMed ID: 23275799 [TBL] [Abstract][Full Text] [Related]
120. Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation. Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM Transl Neurodegener; 2012 Jan; 1(1):2. PubMed ID: 23210740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]